NASDAQ:SRRK

Scholar Rock Holding Stock Insider Trading

Healthcare > Biotechnology

Buy SRRK

*Your capital is at risk

$54.70

-2.01 (-3.54%)

At Close: Jul 13, 2026

Scholar Rock Holding Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -55.54. In total, the insiders bought 3.62M and sold 3.27M SRRK shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-55.54
● Buy	3.62M shares
● Sell	3.27M shares
59% Buy Activity Weak Positive Correlation
Sell Signal Medium Confidence Apr 16, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -55.54. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 01, 2026 Sell	Common Stock S-Sale	Burow Kristina Director	Director	2 105 Value: $112.6K
Jul 01, 2026 Sell	Common Stock S-Sale	Gilman Michael Director	Director	43 Value: $2K
Jul 01, 2026 Sell	Common Stock S-Sale	Gilman Michael Director	Director	1 155 Value: $62.6K
Jul 01, 2026 Sell	Common Stock S-Sale	Gilman Michael Director	Director	1 346 Value: $72.1K
Jul 01, 2026 Sell	Common Stock S-Sale	Flier Jeffrey S. Director	Director	15 Value: $823
Jul 01, 2026 Sell	Common Stock S-Sale	Flier Jeffrey S. Director	Director	1 470 Value: $79.7K
Jul 01, 2026 Sell	Common Stock S-Sale	Flier Jeffrey S. Director	Director	1 568 Value: $83.9K
Jul 01, 2026 Sell	Common Stock S-Sale	Burow Kristina Director	Director	948 Value: $51.5K
Jul 01, 2026 Sell	Common Stock S-Sale	Reed Joshua Director	Director	2 105 Value: $112.6K
Jul 01, 2026 Sell	Common Stock S-Sale	Reed Joshua Director	Director	948 Value: $51.5K
Jul 01, 2026 Sell	Common Stock S-Sale	Peng Katie Director	Director	2 988 Value: $160.0K
Jul 01, 2026 Sell	Common Stock S-Sale	Peng Katie Director	Director	2 437 Value: $132.2K
Jul 01, 2026 Sell	Common Stock S-Sale	Peng Katie Director	Director	21 Value: $1K
Jun 04, 2026 Buy	Stock Option (Right to Buy) A-Award	Akkaraju Srinivas Director	Director	4 310 Value: $195.4K
Jun 04, 2026 Buy	Stock Option (Right to Buy) A-Award	Gilman Michael Director	Director	4 310 Value: $195.4K
Jun 04, 2026 Buy	Common Stock A-Award	Gilman Michael Director	Director	6 839 Value: $310.0K
Jun 04, 2026 Buy	Stock Option (Right to Buy) A-Award	Burow Kristina Director	Director	4 310 Value: $195.4K
Jun 04, 2026 Buy	Stock Option (Right to Buy) A-Award	Brudnick Richard Director	Director	4 310 Value: $195.4K
Jun 04, 2026 Buy	Stock Option (Right to Buy) A-Award	Reed Joshua Director	Director	4 310 Value: $195.4K
Jun 04, 2026 Buy	Stock Option (Right to Buy) A-Award	Flier Jeffrey S. Director	Director	4 310 Value: $195.4K
Jun 04, 2026 Buy	Common Stock A-Award	Flier Jeffrey S. Director	Director	6 839 Value: $310.0K
Jun 04, 2026 Buy	Common Stock A-Award	Reed Joshua Director	Director	6 839 Value: $310.0K
Jun 04, 2026 Buy	Common Stock A-Award	Brudnick Richard Director	Director	6 839 Value: $310.0K
Jun 04, 2026 Buy	Common Stock A-Award	Burow Kristina Director	Director	6 839 Value: $310.0K
Jun 04, 2026 Buy	Common Stock A-Award	Peng Katie Director	Director	6 839 Value: $310.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SCHOLAR ROCK HOLDING CORP.

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical tria...

Read Full Profile Here